Stifel on Ionis Pharmaceuticals (IONS): 'we expect eplontersen to increase Ionis' share within the TTR space'
Tweet Send to a Friend
Stifel analyst Paul Matteis reiterated a Hold rating and {REMOVEPT} price target on Ionis Pharmaceuticals (NASDAQ: IONS)The analyst comments "Ionis ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
